Department of Surgery, Children's Memorial Hospital, Feinberg School of Medicine of Northwestern University, Chicago, Illinois 60614, USA.
Cancer. 2011 May 1;117(9):1976-83. doi: 10.1002/cncr.25722. Epub 2010 Nov 16.
Liver transplantation is increasingly advocated as primary surgical therapy for children with hepatoblastoma involving 3 or 4 sectors of the liver after neoadjuvant chemotherapy. This study evaluated the results of nontransplant hepatectomy in children who might otherwise have been considered for liver transplantation.
All children who underwent resection at a single institution from 1998 to 2009 for POST-TEXT IV or centrally located POST-TEXT III hepatoblastoma after neoadjuvant chemotherapy were reviewed.
Fourteen children (7 boys) with a median age of 8 months at diagnosis met study criteria. Pulmonary metastases in 3 patients were resected in 2 and resolved with chemotherapy in 1 patient. Preoperative grouping after neoadjuvant chemotherapy was POST-TEXT IV in 3 patients and POST-TEXT III in 11 patients. Thirteen of 14 (93%) children who underwent aggressive resection despite being potential candidates for primary transplantation were alive and tumor-free with a median follow-up of 57 months. Observed survival rates at 1, 2, and 5 years were 93%, 91%, and 88% respectively. Event-free survival rates at 1, 2, and 5 years were 93%, 91%, and 75%, respectively.
Excellent survival (93%) was obtained with aggressive resection in children with POST-TEXT III and IV hepatoblastoma meeting criteria for transplant referral. The 1 death occurred in a patient with unfavorable small cell histology. These children should be managed at institutions experienced in both advanced pediatric hepatobiliary surgery and transplantation. Operative exploration was frequently required to ultimately determine which tumors can be resected and which require transplantation.
新辅助化疗后,对于累及肝脏 3 或 4 个象限的 3 或 4 期肝母细胞瘤患儿,越来越提倡采用肝移植作为初始外科治疗方法。本研究评估了对于原本可能考虑进行肝移植的患儿,采用非移植性肝切除术的结果。
回顾了 1998 年至 2009 年期间,在一家单中心接受新辅助化疗后,接受手术切除的 POST-TEXT IV 期或中央型 POST-TEXT III 期肝母细胞瘤患儿的所有病例。
14 名患儿(7 名男性)符合研究标准,诊断时的中位年龄为 8 个月。3 例患儿存在肺转移,2 例患儿转移灶被切除,1 例患儿经化疗后转移灶消失。新辅助化疗后术前分组为 3 例 POST-TEXT IV 期和 11 例 POST-TEXT III 期。尽管 14 例患儿中的 13 例(93%)有成为肝移植首选适应证的潜在可能,但仍进行了积极的切除术,且 13 例(93%)患儿术后肿瘤无进展,中位随访时间为 57 个月。观察到的 1、2 和 5 年生存率分别为 93%、91%和 88%。1、2 和 5 年无事件生存率分别为 93%、91%和 75%。
符合移植转诊标准的 POST-TEXT III 和 IV 期肝母细胞瘤患儿,行积极切除术可获得良好的生存(93%)。1 例死亡患儿的肿瘤组织学表现为小细胞型,预后较差。这些患儿应在同时具有小儿肝胆外科和移植治疗经验的机构进行治疗。通常需要进行手术探查,以最终确定哪些肿瘤可以切除,哪些需要移植。